160 related articles for article (PubMed ID: 32626765)
1. Diosgenin Exerts Antitumor Activity via Downregulation of Skp2 in Breast Cancer Cells.
Liu Y; Zhou Z; Yan J; Wu X; Xu G
Biomed Res Int; 2020; 2020():8072639. PubMed ID: 32626765
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
Wang L; Ye X; Cai X; Su J; Ma R; Yin X; Zhou X; Li H; Wang Z
Oncotarget; 2015 Jul; 6(20):18027-37. PubMed ID: 26046466
[TBL] [Abstract][Full Text] [Related]
3. Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells.
Mou H; Guo P; Li X; Zhang C; Jiang J; Wang L; Wang Q; Yuan Z
Cell Cycle; 2017 Jul; 16(14):1366-1375. PubMed ID: 28594256
[TBL] [Abstract][Full Text] [Related]
4. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells.
Yin X; Zhang Y; Su J; Hou Y; Wang L; Ye X; Zhao Z; Zhou X; Li Y; Wang Z
Oncotarget; 2016 Oct; 7(41):66512-66524. PubMed ID: 27582552
[TBL] [Abstract][Full Text] [Related]
5. MiR-506 exerts antineoplastic effects on osteosarcoma cells via inhibition of the Skp2 oncoprotein.
Ding L; Sun R; Yan Q; Wang C; Han X; Cui Y; Li R; Liu J
Aging (Albany NY); 2021 Feb; 13(5):6724-6739. PubMed ID: 33621206
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of S-phase kinase-associated protein-2 expression in MCF-7 inhibits cell growth and enhances the cytotoxic effects of epirubicin.
Sun L; Cai L; Yu Y; Meng Q; Cheng X; Zhao Y; Sui G; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2007 Dec; 39(12):999-1007. PubMed ID: 18064393
[TBL] [Abstract][Full Text] [Related]
7. 1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein.
Huang HC; Lin CL; Lin JK
J Agric Food Chem; 2011 Jun; 59(12):6765-75. PubMed ID: 21598989
[TBL] [Abstract][Full Text] [Related]
8. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.
Huang HC; Way TD; Lin CL; Lin JK
Endocrinology; 2008 Dec; 149(12):5972-83. PubMed ID: 18719023
[TBL] [Abstract][Full Text] [Related]
9. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.
Koo KH; Kim H; Bae YK; Kim K; Park BK; Lee CH; Kim YN
Cell Death Dis; 2013 Jun; 4(6):e693. PubMed ID: 23807222
[TBL] [Abstract][Full Text] [Related]
10. [Over-expression of human S-phase kinase-associated protein 2 (Skp2) promotes proliferation of MCF-7 breast cancer cells and increases the number of S phase cells].
Yang C; Nan K; Qin S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Oct; 31(10):1306-10. PubMed ID: 26429528
[TBL] [Abstract][Full Text] [Related]
11. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
[TBL] [Abstract][Full Text] [Related]
12. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
[TBL] [Abstract][Full Text] [Related]
13. Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells.
Liao WL; Lin JY; Shieh JC; Yeh HF; Hsieh YH; Cheng YC; Lee HJ; Shen CY; Cheng CW
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31881805
[TBL] [Abstract][Full Text] [Related]
14. Skp2 regulates subcellular localization of PPARγ by MEK signaling pathways in human breast cancer.
Cheng H; Meng J; Wang G; Meng Y; Li Y; Wei D; Fu C; Deng K; Shen A; Wang H; Dai S
Int J Mol Sci; 2013 Aug; 14(8):16554-69. PubMed ID: 23939428
[TBL] [Abstract][Full Text] [Related]
15. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
[TBL] [Abstract][Full Text] [Related]
16. Bortezomib-mediated downregulation of S-phase kinase protein-2 (SKP2) causes apoptotic cell death in chronic myelogenous leukemia cells.
Iskandarani A; Bhat AA; Siveen KS; Prabhu KS; Kuttikrishnan S; Khan MA; Krishnankutty R; Kulinski M; Nasr RR; Mohammad RM; Uddin S
J Transl Med; 2016 Mar; 14():69. PubMed ID: 26956626
[TBL] [Abstract][Full Text] [Related]
17. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
18. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway.
Foster JS; Fernando RI; Ishida N; Nakayama KI; Wimalasena J
J Biol Chem; 2003 Oct; 278(42):41355-66. PubMed ID: 12904306
[TBL] [Abstract][Full Text] [Related]
19. Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation.
Chiang CT; Way TD; Tsai SJ; Lin JK
FEBS Lett; 2007 Dec; 581(30):5735-42. PubMed ID: 18022396
[TBL] [Abstract][Full Text] [Related]
20. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
